Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05815 | 33109219 | Lipids Health Dis | Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study. | 2020 | Details |
| A05820 | 33106141 | Curr Mol Med | Critical Role of NFκB in the Pathogenesis of Non-alcoholic Fatty Liver Disease: A Widespread Key Regulator. | 2021 | Details |
| A05821 | 33106137 | Curr Pharm Des | Therapeutic effect of Prdx1 on NAFLD mice may be related to the activation of Nrf-2/HO-1 pathway. | 2020 | Details |
| A05826 | 33105887 | Biology (Basel) | Lauric Acid versus Palmitic Acid: Effects on Adipose Tissue Inflammation, Insulin Resistance, and Non-Alcoholic Fatty Liver Disease in Obesity. | 2020 | Details |
| A05828 | 33105604 | Int J Mol Sci | Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor. | 2020 | Details |
| A05832 | 33103454 | Am J Physiol Endocrinol Metab | GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice. | 2020 | Details |
| A05836 | 33102799 | Endocrinol Diabetes Metab | Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum. | 2020 | Details |
| A05840 | 33102794 | Endocrinol Diabetes Metab | The metabolic basis of nonalcoholic steatohepatitis. | 2020 | Details |
| A05844 | 33102766 | JGH Open | Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non-alcoholic fatty liver disease patients. | 2020 | Details |
| A05851 | 33101626 | Frontline Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals. | 2019 | Details |
| A05852 | 33101480 | Exp Ther Med | Prediction of NAFLD occurrence in prediabetes patients. | 2020 | Details |
| A05854 | 33101202 | Front Endocrinol (Lausanne) | Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women. | 2020 | Details |
| A05861 | 33097932 | J Nutr | Soy Food Intake Is Inversely Associated with Newly Diagnosed Nonalcoholic Fatty Liver Disease in the TCLSIH Cohort Study. | 2020 | Details |
| A05863 | 33096235 | J Nutr Biochem | Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in rats. | 2020 | Details |
| A05864 | 33096115 | Life Sci | The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. | 2020 | Details |
| A05866 | 33096076 | Metabolism | Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability. | 2020 | Details |
| A05870 | 33094956 | Clin Transl Gastroenterol | Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05873 | 33093014 | Diabetes | ETV5 Regulates Hepatic Fatty Acid Metabolism Through PPAR Signaling Pathway. | 2020 | Details |
| A05907 | 33079450 | Mol Nutr Food Res | The Beneficial Effects of Apical Sodium-Dependent Bile Acid Transporter Inactivation Depend on Dietary Fat Composition. | 2020 | Details |
| A05909 | 33078906 | FASEB J | Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism. | 2020 | Details |
| A05923 | 33075504 | Diabetes Metab | Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study. | 2020 | Details |
| A05927 | 33073044 | Transl Gastroenterol Hepatol | Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease. | 2020 | Details |
| A05933 | 33071981 | Front Endocrinol (Lausanne) | Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function. | 2020 | Details |
| A05944 | 33067796 | J Endocrinol Invest | Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome. | 2020 | Details |
| A05946 | 33067533 | Sci Rep | HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse. | 2020 | Details |
| A05947 | 33066497 | J Pers Med | Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development. | 2020 | Details |
| A05952 | 33064664 | Endocr Connect | The hepatic lipidome and HNF4α and SHBG expression in human liver. | 2020 | Details |
| A05953 | 33064150 | J Clin Endocrinol Metab | The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. | 2021 | Details |
| A05954 | 33063664 | Elife | Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver. | 2020 | Details |
| A05958 | 33061754 | Turk Pediatri Ars | The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity. | 2020 | Details |
| A05959 | 33061687 | Hepat Med | Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2020 | Details |
| A05964 | 33060043 | Dig Liver Dis | Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. | 2020 | Details |
| A05971 | 33058486 | Pediatr Obes | A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity. | 2020 | Details |
| A05972 | 33057854 | Curr Diab Rep | Tissue-Specific Fructose Metabolism in Obesity and Diabetes. | 2020 | Details |
| A05976 | 33053981 | Zhonghua Gan Zang Bing Za Zhi | [Physical activity intervention for non-alcoholic fatty liver disease in children]. | 2020 | Details |
| A05986 | 33050482 | Int J Mol Sci | Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: 2H2O-Metabolic Labeling-Based Kinetic Approach. | 2020 | Details |
| A05991 | 33049668 | Front Biosci (Landmark Ed) | Current treatment paradigms and emerging therapies for NAFLD/NASH. | 2021 | Details |
| A05997 | 33045675 | J Trace Elem Med Biol | A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. | 2020 | Details |
| A06003 | 33040692 | Trop Doct | Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease. | 2020 | Details |
| A06018 | 33037656 | Clin Endocrinol (Oxf) | Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease. | 2020 | Details |
| A06020 | 33037249 | Sci Rep | Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis. | 2020 | Details |
| A06022 | 33036939 | Surg Obes Relat Dis | Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. | 2020 | Details |
| A06027 | 33035599 | Diabetes Res Clin Pract | Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial. | 2020 | Details |
| A06028 | 33035588 | Life Sci | Nicotinamide and ascorbic acid nanoparticles against the hepatic insult induced in rats by high fat high fructose diet: A comparative study. | 2020 | Details |
| A06034 | 33033564 | World J Hepatol | Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases. | 2020 | Details |
| A06038 | 33032263 | J Endocrinol | Lactobacillus pentosus strain S-PT84 improves steatohepatitis by maintaining gut permeability. | 2020 | Details |
| A06040 | 33031969 | Ann Hepatol | Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures. | 2020 | Details |
| A06049 | 33028338 | Lipids Health Dis | The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. | 2020 | Details |
| A06053 | 33027655 | Cell Rep | The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. | 2020 | Details |
| A06058 | 33025629 | NMR Biomed | In vivo absolute quantification of hepatic γ-ATP concentration in mice using 31 P MRS at 11.7 T. | 2020 | Details |
| A06062 | 33024913 | Hepatol Commun | Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity. | 2020 | Details |
| A06074 | 33015726 | Curr Diab Rep | Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06081 | 33013688 | Front Endocrinol (Lausanne) | Abdominal Adiposity and Total Body Fat as Predictors of Cardiometabolic Health in Children and Adolescents With Obesity. | 2020 | Details |
| A06088 | 33011191 | Prog Lipid Res | The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation. | 2020 | Details |
| A06089 | 33010471 | Mol Metab | Dysregulated lipid metabolism links NAFLD to cardiovascular disease. | 2020 | Details |
| A06097 | 33008924 | J Lipid Res | Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition. | 2020 | Details |
| A06099 | 33007695 | Food Chem | Polyphenols of cambuci (Campomanesia phaea (O. Berg.)) fruit ameliorate insulin resistance and hepatic steatosis in obese mice. | 2020 | Details |
| A06109 | 33004402 | BMJ Open Diabetes Res Care | Metabolic and energetic benefits of microRNA-22 inhibition. | 2020 | Details |
| A06111 | 33003574 | J Clin Med | Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose. | 2020 | Details |
| A06112 | 33002297 | Mol Nutr Food Res | Huangjinya Black Tea Alleviates Obesity and Insulin Resistance via Modulating Fecal Metabolome in High-Fat Diet-Fed Mice. | 2020 | Details |
| A06113 | 33002003 | PLoS One | REV-ERB agonism improves liver pathology in a mouse model of NASH. | 2020 | Details |
| A06114 | 33001570 | Diabetes Obes Metab | Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice. | 2020 | Details |
| A06122 | 32998095 | Diabetes Metab Syndr | Pathophysiological mechanisms underlying MAFLD. | 2020 | Details |
| A06130 | 32994765 | Postepy Dermatol Alergol | Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications. | 2019 | Details |
| A06134 | 32993686 | J Neuroinflammation | Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease. | 2020 | Details |
| A06139 | 32992082 | Phytomedicine | Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse. | 2020 | Details |
| A06140 | 32991990 | J Steroid Biochem Mol Biol | Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome. | 2020 | Details |
| A06144 | 32990607 | Asia Pac J Clin Nutr | Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease. | 2020 | Details |
| A06147 | 32987188 | Mol Metab | Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease. | 2020 | Details |
| A06155 | 32984791 | JHEP Rep | Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. | 2020 | Details |
| A06156 | 32984364 | Front Med (Lausanne) | Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases. | 2020 | Details |
| A06157 | 32982804 | Front Physiol | Newly Discovered Adipokines: Pathophysiological Link Between Obesity and Cardiometabolic Disorders. | 2020 | Details |
| A06164 | 32981386 | Expert Rev Clin Pharmacol | The pharmacological treatment of nonalcoholic fatty liver disease in children. | 2020 | Details |
| A06165 | 32981283 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | [Effects of liraglutide combined with vitamin D on non-alcoholic fatty liver induced by high fat in mice and its mechanism]. | 2020 | Details |
| A06172 | 32979184 | Obes Surg | Prevalence and Factors Associated with Hepatic Iron Overload in Obese Individuals Undergoing Bariatric Surgery: a Cross-Sectional Study. | 2020 | Details |
| A06178 | 32978491 | Sci Rep | FIB-4 index is a marker for a subsequent decrease in insulin secretion in a non-diabetic Japanese population. | 2020 | Details |
| A06182 | 32977558 | Molecules | Distinct Influence of Hypercaloric Diets Predominant with Fat or Fat and Sucrose on Adipose Tissue and Liver Inflammation in Mice. | 2020 | Details |
| A06184 | 32977263 | J Affect Disord | Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation. | 2020 | Details |
| A06190 | 32975679 | Adv Ther | Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2020 | Details |
| A06195 | 32973925 | Therap Adv Gastroenterol | The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. | 2020 | Details |
| A06196 | 32973715 | Front Microbiol | Constant Light Exposure Alters Gut Microbiota and Promotes the Progression of Steatohepatitis in High Fat Diet Rats. | 2020 | Details |
| A06210 | 32966467 | Food Funct | Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2020 | Details |
| A06218 | 32964054 | J Diabetes Res | Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients. | 2020 | Details |
| A06219 | 32963741 | Iran J Basic Med Sci | The role of acylated ghrelin and unacylated ghrelin in the blood and hypothalamus and their interaction with nonalcoholic fatty liver disease. | 2020 | Details |
| A06220 | 32963510 | PPAR Res | Diet Modifies Pioglitazone's Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression. | 2020 | Details |
| A06227 | 32961669 | Nutrients | Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2020 | Details |
| A06228 | 32961610 | J Diabetes Investig | Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. | 2020 | Details |
| A06232 | 32961235 | Life Sci | Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice. | 2020 | Details |
| A06235 | 32959866 | Food Funct | Two polyphenol-rich Brazilian fruit extracts protect from diet-induced obesity and hepatic steatosis in mice. | 2020 | Details |
| A06238 | 32958032 | Orphanet J Rare Dis | Consensus clinical management guidelines for Alström syndrome. | 2020 | Details |
| A06243 | 32953932 | Mol Ther Methods Clin Dev | Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes. | 2020 | Details |
| A06251 | 32952340 | World J Gastroenterol | Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice. | 2020 | Details |
| A06255 | 32951743 | Complement Ther Med | Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2020 | Details |
| A06256 | 32951715 | Complement Ther Med | The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial. | 2020 | Details |
| A06258 | 32951410 | Clin Mol Hepatol | Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases. | 2020 | Details |
| A06263 | 32947952 | Nutrients | Anti-Diabetic Obesity Effects of Wasabia Japonica Matsum Leaf Extract on 45% Kcal High-Fat Diet-Fed Mice. | 2020 | Details |
| A06273 | 32945305 | Food Funct | Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. | 2020 | Details |
| A06274 | 32945071 | Diabetes Obes Metab | A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer? | 2020 | Details |
| A06277 | 32944984 | J Food Biochem | trans-Chalcone inhibits high-fat diet-induced disturbances in FXR/SREBP-1c/FAS and FXR/Smad-3 pathways in the kidney of rats. | 2020 | Details |
| A06278 | 32943763 | Int J Obes (Lond) | Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery. | 2020 | Details |